obesity research is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-06-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
== Clinical significance == Alterations in the KISS1/KISS1R signaling pathway have been linked to multiple physiological conditions, including metabolic and reproductive abnormalities. A knockout model of GPR54/KISS1R in mice showed hypogonadism, and the mice failed to reach puberty. The KISS1 gene has been stated to suppress the metastasis of malignant melanomas. KISS1R signaling pathway has been characterized in the suppression of tumors and has anti-metastatic effects in several cancers, including breast cancer. Activation of KISS1R elicits a neuroendocrine response leading to pubertal maturation. This is indicated by intermittent kisspeptin-10 administration to pre-pubertal animals resulting in activation of the hypothalamic-pituitary axis and subsequent precocious puberty in rats and primates. Mutations in the kisspeptin receptor KISS1R have resulted in isolated hypogonadotropic hypogonadism (IHH), characterized by delayed or absence of puberty
In 1995, another Media Act was enacted, which saw the NOS's broadcasting duties greatly reduced, with the creation of the Nederlandse Programma Stichting (Netherlands Programming Service; NPS). The NPS took on the NOS's programming tasks concerning culture, art, children, education, and ethnic minorities, while the NOS concentrated on news, sports, and live events. A new Supervisory Board replaced the Board of Directors in 1998. The previous management was replaced with a three-man board, now charged with developing strategies and responsibility for all public output. Programming co-ordinators were appointed for each television and radio network and channel identities were created, largely replacing the varying on-air presentation of the pillar broadcasters. The broadcasting associations also have a degree of input through the Supervisory Board. In 2002, the coordination element of the public broadcast system, administered by the NOS was now made clearer with the creation of an umbrella organisation, Publieke Omroep (Public Broadcasting), while programme makers operated under the name "RTV NOS". The reorganisation loosened NOS from the public broadcasting system and reconstituted it as a neutral member of the NPO.
== Early and personal life == Epstein was born in the Bronx, New York, and is Jewish. His parents were Jack (a salesman, born in Toronto, Ontario, Canada) and Evelyn (born in New York City). When he was three years old, his family moved to Hartsdale, New York, and then when he was 13 to the Fairfax District in Los Angeles, California. Epstein said of his father, who refused when Epstein was still a minor to sign a contract on his behalf with the Dodgers: "He wanted me to be a lawyer, rather than a bum."
== Personal life == Springer is a gongshi collector. Springer is married to Chafen Lu, a former assistant professor at Harvard Medical School and an alumnus of his lab. He has five children, three from his first marriage.
Sources: en.wikipedia.org
== Further reading == Press Conference by professor Samuel S. Epstein M.D. 1999-05-31 World Trade Organization (2000). Dispute Settlement Reports 1998. Cambridge University Press. p. 79. ISBN 0-521-78895-1. Galbraith, H. (December 2002). "Hormones in international meat production: biological, sociological and consumer issues". Nutrition Research Reviews. 15 (2). CABI Publishing: 293–314. doi:10.1079/NRR200246. PMID 19087409. M. Ellin Doyle. "Human Safety of Hormone Implants Used to Promote Growth in Cattle". National Cattlemen's Foundation. Archived from the original (Microsoft Word) on 7 May 2006. J. J. Kastner & R. K. Pawsey (29 November 2001). "Harmonising sanitary measures and resolving trade disputes through the WTO–SPS framework. Part I: a case study of the US–EU hormone-treated beef dispute" (PDF). Food Control. 13. Elsevier Science Ltd.: 49–55. doi:10.1016/S0956-7135(01)00023-8. Archived from the original (PDF) on 21 May 2004. Tim Josling; Donna Roberts & Ayesha Hassan (12 April 2000). "The Beef-Hormone Dispute and its Implications for Trade Policy" (PDF). Stanford University. Archived from the original (PDF) on 11 June 2007. Grace Skogstad (September 2001). "The WTO and Food Safety Regulatory Policy Innovation in the European Union". Journal of Common Market Studies. 39 (3): 485–505. doi:10.1111/1468-5965.00300. Christina L. Davis (2003). "Battles over Beef: The Beef Hormone Dispute". Food Fights Over Free Trade: How International Institutions Promote Agricultural Trade Liberalization. Princeton University Press. pp. 321–337. ISBN 0-691-11505-2.
=== Architecture === Between 1888 and 1892, Raymond traveled to ancient cities of Konya, Iznik, Bursa, Yenişehir and made drawings of Islamic architecture. From 1894, Raymond drew the blueprints for the Bursa Institute of Sericulture, an Ankara agency building – probably that of Régie de Tabac, and an Adapazarı agency building of Régie de Tabac. In 1908, he published L’Art de la Construction en Turquie (The Art of Construction in Turkey, in French), dealing with the construction market, material and labor conditions, and technical and legal arrangements in the Ottoman Empire at the beginning of the 20th century. He partnered with his brother César who ran a bookshop, Librairie Raymond, where his written works were sold.
Staining is a technique used to enhance contrast in samples, generally at the microscopic level. Stains and dyes are frequently used in histology (microscopic study of biological tissues), in cytology (microscopic study of cells), and in the medical fields of histopathology, hematology, and cytopathology that focus on the study and diagnoses of diseases at the microscopic level. Stains may be used to define biological tissues (highlighting, for example, muscle fibers or connective tissue), cell populations (classifying different blood cells), or organelles within individual cells. In biochemistry, it involves adding a class-specific (DNA, proteins, lipids, carbohydrates) dye to a substrate to qualify or quantify the presence of a specific compound. Staining and fluorescent tagging can serve similar purposes. Biological staining is also used to mark cells in flow cytometry, and to flag proteins or nucleic acids in gel electrophoresis. Light microscopes are used for viewing stained samples at high magnification, typically using bright-field or epi-fluorescence illumination. Staining is not limited to only biological materials, since it can also be used to study the structure of other materials; for example, the lamellar structures of semi-crystalline polymers or the domain structures of block copolymers.
=== 2008 days-in-a-week debate === The forums are notable for a thread titled "Full Body Workout Every Other Day?", created on May 17, 2008, in which two users had a long and intense debate over the number of days in a week. It started when user m1ndless posted: "If I go [to the gym] every other day I will be at the gym 4-5 times a week, is that over training? [...]" User steviekm3 responded: "That makes no sense. There are only 7 days in a week. If you go every other day that is 3.5 times a week." m1ndless, posting as "TheJosh" from this point on, responded: "Monday, Wednesday, Friday, Sunday. That is 4 days. How do you go 3.5 times? Do a half workout or something? lol". User Justin27 agreed with stevekm3: "7x in 2 weeks = 3.5 times a week, genius."
=== Metabolism === Strychnine is rapidly metabolized by the liver microsomal enzyme system requiring NADPH and O2. Strychnine competes with the inhibitory neurotransmitter glycine resulting in an excitatory state. However, the toxicokinetics after overdose have not been well described. In most severe cases of strychnine poisoning, the patient dies before reaching the hospital. The biological half-life of strychnine is about 10 hours.
Sources: en.wikipedia.org
Like many lichens, Xanthoria parietina produces various secondary metabolites (lichen substances), primarily anthraquinone pigments that contribute to its vivid color. Its dominant compound, parietin, is an orange-yellow anthraquinone that accumulates in the outer cortex and is sometimes referred to as physcion in chemical literature. Parietin typically makes up 2.1% of the thallus dry weight and forms a hydrophobic layer in the upper cortex above the algal layer. It is deposited as tiny crystals in the upper cortex, where it protects the photobiont. Parietin synthesis is stimulated by UV-B radiation and photosynthates from the Trebouxia symbiont. In addition to shielding against UV radiation, parietin acts as a barrier against environmental toxins, particularly heavy metals. Parietin, an anthraquinone pigment, not only gives X. parietina its bright orange color but also protects it from visible light (400–500 nm). Experimental removal of parietin led to increased photoinhibition, especially in hydrated thalli, confirming its protective function. However, when desiccated, X. parietina remained phototolerant, suggesting that structural adaptations also contribute to its light resistance. In addition to its role in photoprotection, parietin enhances desiccation tolerance by stabilizing cell membranes and modifying the upper cortex to improve water retention. Parietin is highly effective in UV protection, absorbing UV-B radiation with a peak at 288 nm. This trait is particularly beneficial in UV-intense habitats such as coastal cliffs and alpine regions.
==== Deep anterior lamellar keratoplasty ==== In this procedure, the anterior layers of the central cornea are removed and replaced with donor tissue. Endothelial cells and the Descemets membrane are left in place. This technique is used in cases of anterior corneal opacifications, scars, and ectatic diseases such as keratoconus.
Astatine is a chemical element; it has symbol At and atomic number 85. It is the rarest naturally occurring element in the Earth's crust, occurring only as the decay product of various heavier elements. All of astatine's isotopes are short-lived; the most stable is astatine-210, with a half-life of 8.1 hours. Consequently, a solid sample of the element has never been seen, because any macroscopic specimen would be immediately vaporized by the heat of its radioactivity. The bulk properties of astatine are not known with certainty. Many of them have been estimated from its position on the periodic table as a heavier analog of fluorine, chlorine, bromine, and iodine, the four stable halogens. However, astatine also falls roughly along the dividing line between metals and nonmetals, and some metallic behavior has also been observed and predicted for it. Astatine is likely to have a dark or lustrous appearance and may be a semiconductor or possibly a metal. Chemically, several anionic species of astatine are known and most of its compounds resemble those of iodine, but it also sometimes displays metallic characteristics and shows some similarities to silver. The first synthesis of astatine was in 1940 by Dale R. Corson, Kenneth Ross MacKenzie, and Emilio G. Segrè at the University of California, Berkeley. They named it from the Ancient Greek ástatos (ἄστατος) 'unstable'. Four isotopes of astatine were subsequently found to be naturally occurring, although much less than one gram is present at any given time in the Earth's crust.
== External links == The MEROPS online database for peptidases and their inhibitors: M13.001 Archived 2019-09-12 at the Wayback Machine Neprilysin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: P08473 (Neprilysin) at the PDBe-KB. This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.